Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease

Atherosclerosis

Volumn 202, Issue 1, 2009, Pages 211-215

  Folsom, Aaron R ^a   Peacock, James M ^a   Boerwinkle, Eric ^b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

LDL cholesterol; PCSK9; Peripheral arterial disease; Prospective study; Total cholesterol

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLAUDICATION; CONTROLLED STUDY; ETHNICITY; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

CHOLESTEROL, LDL; COHORT STUDIES; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SERINE ENDOPEPTIDASES;

EID: 57649193160     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.03.009     Document Type: Article

References (18)

1. Belch J.J., Topol E.J., Agnelli G., et al., For the Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163 (2003) 884-892
2. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
3. Heald C.L., Fowkes F.G., Murray G.D., Price J.F., and For the Ankle Brachial Index Collaboration. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis 189 (2006) 61-69
4. Cohen J.C., Boerwinkle E., Mosley Jr. T.H., and Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 354 (2006) 1264-1272
5. Cohen J., Pertsemlidis A., Kotowski I.K., et al. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in CSK9. Nat Genet 37 (2005) 161-165
6. Hooper A.J., Marais A.D., Tanyanyiwa D.M., and Burnett J.R. The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population. Atherosclerosis 193 (2007) 445-448
7. Scartezini M., Hubbart C., Whittall R.A., et al. The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in UK healthy men. Clin Sci (Lond.) 113 (2007) 435-441
8. Hallman D.M., Srinivasan S.R., Chen W., Boerwinkle E., and Berenson G.S. Relation of PCSK9 mutations to serum low-density lipoprotein cholesterol in childhood and adulthood (from the Bogalusa Heart Study). Am J Cardiol 100 (2007) 69-72
9. Horton J.D., Cohen J.C., and Hobbs H.H. Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci 32 (2007) 71-77
10. ARIC Investigators. ARIC Study Website. Available at http://www.cscc.unc.edu/aric/ [accessed January 30, 2007].
11. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
12. Folsom A.R., Wu K.K., Rosamond W.D., Sharrett A.R., and Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96 (1997) 1102-1108
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20:1183-97.
14. Baecke J.A., Burema J., and Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36 (1982) 936-942
15. Mundt K.A., Chambless L.E., Burnham C.B., and Heiss G. Measuring ankle systolic blood pressure: validation of the Dinamap 1846 SX. Angiology 43 (1992) 555-566
16. ARIC: Atherosclerosis Risk in Communities Study: manual 6A: ultrasound assessment (1987), Chapel Hill, National Heart, Lung, and Blood Institute
17. Dormandy J., Heck L., and Vig S. Intermittent claudication: a condition with underrated risks. Semin Vasc Surg 12 (1999) 96-108
18. Rose G.A., Blackburn H., Gillum R.F., and Prineas R.J. Cardiovascular survey methods (1982), World Health Organization, Geneva